Long-Term Outcomes of Aortic Stenosis Patients with Different Flow/Gradient Patterns Undergoing Transcatheter Aortic Valve Implantation

George Oikonomou,Anastasios Apostolos,Maria Drakopoulou,Chryssavgi Simopoulou,Maria Karmpalioti,Pantelis Toskas,Konstantinos Stathogiannis,Maria Xanthopoulou,Nikolaos Ktenopoulos,George Latsios,Andreas Synetos,Constantinos Tsioufis,Konstantinos Toutouzas

DOI: https://doi.org/10.3390/jcm13051200

IF: 3.9

2024-02-21

Journal of Clinical Medicine

Abstract:Background: Few data exist on the comparative long-term outcomes of severe aortic stenosis (AS) patients with different flow-gradient patterns undergoing transcatheter aortic valve implantation (TAVI). This study sought to evaluate the impact of the pre-TAVI flow-gradient pattern on long-term clinical outcomes after TAVI and assess changes in the left ventricular ejection fraction (LVEF) of different subtypes of AS patients following TAVI. Methods: Consecutive patients with severe AS undergoing TAVI in our institution were screened and prospectively enrolled. Patients were divided into four subgroups according to pre-TAVI flow/gradient pattern: (i) low flow—low gradient (LF-LG): stroke volume indexed (SVi) ≤ 35 mL/m2 and mean gradient (MG) 35 mL/m2 and MG 35 mL/m2 and MG ≥ 40 mmHg. Transthoracic echocardiography was repeated at 1-year follow-up. Clinical follow-up was obtained at 12 months, and yearly thereafter until 5-year follow-up was complete for all patients. Results: A total of 272 patients with complete echocardiographic and clinical follow-up were included in our analysis. Their mean age was 80 ± 7 years and the majority of patients (N = 138, 50.8%) were women. 62 patients (22.8% of the study population) were distributed in the LF-LG group, 98 patients (36%) were LF-HG patients, 95 patients (34.9%) were NF-HG, and 17 patients (6.3%) were NF-LG. There was a greater prevalence of comorbidities among LF-LG AS patients. One-year all-cause mortality differed significantly between the four subgroups of AS patients (log-rank p: 0.022) and was more prevalent among LF-LG patients (25.8%) compared to LF-HG (11.3%), NF-HG (6.3%) and NF-LG patients (18.8%). At 5-year follow-up, global mortality remained persistently higher among LF-LG patients (64.5%) compared to LF-HG (47.9%), NF-HG (42.9%), and NF-LG patients (58.8%) (log-rank p: 0.029). At multivariable Cox hazard regression analysis, baseline SVi (HR: 0.951, 95% C.I.; 0.918–0.984), the presence of at least moderate tricuspid regurgitation at baseline (HR: 3.091, 95% C.I: 1.645–5.809) and at least moderate paravalvular leak (PVL) post-TAVI (HR: 1.456, 95% C.I.: 1.106–1.792) were significant independent predictors of late global mortality. LF-LG patients and LF-HG patients exhibited a significant increase in LVEF at 1-year follow-up. A lower LVEF (p < 0.001) and a lower Svi (p < 0.001) at baseline were associated with LVEF improvement at 1-year. Conclusions: Patients with LF-LG AS have acceptable 1-year outcomes with significant improvement in LVEF at 1-year follow-up, but exhibit exceedingly high 5-year mortality following TAVI. The presence of low transvalvular flow and at least moderate tricuspid regurgitation at baseline and significant paravalvular leak post-TAVI were associated with poorer long-term outcomes in the entire cohort of AS patients. The presence of a low LVEF or a low SVi predicts LVEF improvement at 1-year.

medicine, general & internal

What problem does this paper attempt to address?

The paper aims to explore the long-term clinical outcomes of patients with severe aortic stenosis (AS) who undergo transcatheter aortic valve implantation (TAVI) under different flow/gradient patterns. Specifically, the study objectives include:

1. **Assessing the impact of pre-TAVI flow/gradient patterns on long-term clinical outcomes**:
- The study compared the long-term clinical outcomes of patients with four different patterns: low-flow low-gradient (LF-LG), normal-flow low-gradient (NF-LG), low-flow high-gradient (LF-HG), and normal-flow high-gradient (NF-HG) after TAVI.

2. **Evaluating changes in left ventricular ejection fraction (LVEF)**:
- The study also assessed the changes in LVEF one year after TAVI in patients with different AS subtypes.

Through these objectives, the study hopes to provide clinicians with important information regarding the expected outcomes and associated risk factors for different types of AS patients undergoing TAVI treatment.